Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.
Scott JM, Lee J, Herndon JE, Michalski MG, Lee CP, O'Brien KA, Sasso JP, Yu AF, Rowed KA, Bromberg JF, Traina TA, Gucalp A, Sanford RA, Gajria D, Modi S, Comen EA, D'Andrea G, Blinder VS, Eves ND, Peppercorn JM, Moskowitz CS, Dang CT, Jones LW. Scott JM, et al. Among authors: herndon je. Eur Heart J. 2023 Dec 7;44(46):4878-4889. doi: 10.1093/eurheartj/ehad085. Eur Heart J. 2023. PMID: 36806405 Free PMC article. Clinical Trial.
Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.
Thompson EM, Landi D, Brown MC, Friedman HS, McLendon R, Herndon JE 2nd, Buckley E, Bolognesi DP, Lipp E, Schroeder K, Becher OJ, Friedman AH, McKay Z, Walter A, Threatt S, Jaggers D, Desjardins A, Gromeier M, Bigner DD, Ashley DM. Thompson EM, et al. Among authors: herndon je 2nd. Lancet Child Adolesc Health. 2023 Jul;7(7):471-478. doi: 10.1016/S2352-4642(23)00031-7. Epub 2023 Mar 30. Lancet Child Adolesc Health. 2023. PMID: 37004712 Clinical Trial.
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery.
Carpenter DJ, Fairchild AT, Adamson JD, Fecci PE, Sampson JH, Herndon JE, Torok JA, Mullikin TC, Kim GJ, Reitman ZJ, Kirkpatrick JP, Floyd SR. Carpenter DJ, et al. Among authors: herndon je. Adv Radiat Oncol. 2022 Dec 29;8(2):101166. doi: 10.1016/j.adro.2022.101166. eCollection 2023 Mar-Apr. Adv Radiat Oncol. 2022. PMID: 36845614 Free PMC article.
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models.
Parker S, McDowall C, Sanchez-Perez L, Osorio C, Duncker PC, Briley A, Swartz AM, Herndon JE 2nd, Yu YA, McLendon RE, Tedder TF, Desjardins A, Ashley DM, Gunn MD, Enterline DS, Knorr DA, Pastan IH, Nair SK, Bigner DD, Chandramohan V. Parker S, et al. Among authors: herndon je 2nd. Sci Transl Med. 2023 Feb 8;15(682):eabn5649. doi: 10.1126/scitranslmed.abn5649. Epub 2023 Feb 8. Sci Transl Med. 2023. PMID: 36753564 Free PMC article.
Variation in Oral Board Examination Accommodations Among Specialties.
Rowe DG, Charles AJ, Luo EJ, Arango AM, Herndon JE 2nd, Hockenberry H, Shortell CK, Goodwin CR, Erickson MM. Rowe DG, et al. Among authors: herndon je 2nd. JAMA Netw Open. 2024 May 1;7(5):e2410127. doi: 10.1001/jamanetworkopen.2024.10127. JAMA Netw Open. 2024. PMID: 38713464 Free PMC article.
Automated Segmentation of Ablated Lesions Using Deep Convolutional Neural Networks: A Basis for Response Assessment Following Laser Interstitial Thermal Therapy.
Haskell-Mendoza AP, Reason EH, Gonzalez AT, Jackson JD, Sankey EW, Srinivasan ES, Herndon JE 2nd, Fecci PE, Calabrese E. Haskell-Mendoza AP, et al. Among authors: herndon je 2nd. Neuro Oncol. 2024 Jan 3:noad261. doi: 10.1093/neuonc/noad261. Online ahead of print. Neuro Oncol. 2024. PMID: 38170451
ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination.
Jones JK, Zhang H, Lyne AM, Cavalli FMG, Hassen WE, Stevenson K, Kornahrens R, Yang Y, Li S, Dell S, Reitman ZJ, Herndon JE 2nd, Hoj J, Pendergast AM, Thompson EM. Jones JK, et al. Among authors: herndon je 2nd. Neurooncol Adv. 2023 Aug 7;5(1):vdad095. doi: 10.1093/noajnl/vdad095. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37781087 Free PMC article.
CD155 is a putative therapeutic target in medulloblastoma.
Li S, McLendon R, Sankey E, Kornahrens R, Lyne AM, Cavalli FMG, McKay Z, Herndon JE 2nd, Remke M, Picard D, Gromeier M, Brown M, Thompson EM. Li S, et al. Among authors: herndon je 2nd. Clin Transl Oncol. 2023 Mar;25(3):696-705. doi: 10.1007/s12094-022-02975-9. Epub 2022 Oct 27. Clin Transl Oncol. 2023. PMID: 36301489
361 results